A follow-up study on treatment effects of cognitive-behavioral therapy on social anxiety disorder: Impact of COVID-19 fear during post-lockdown periodResearch article Published on 2022-04-012022-10-05 Journal: Psychiatry research [Category] 치료법, [키워드] Anxiety CBT cognitive behavioral therapy cognitive-behavioral therapy Comorbidity COVID-19 COVID-19 pandemic disorder fear follow-up study Hierarchical Impact individual Intervention inventory less lockdown mental health Multiple regression phobia positively correlated post-intervention predicted Research severity significantly significantly more social distancing Social phobia therapy treatment effect [DOI] 10.1016/j.psychres.2022.114439 [Article Type] Research article
[Correlations between genetic polymorphism of IFN-λ family gene and HBV infection, virus replication and clearance]Review Published on 2022-03-252023-06-12 Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Category] B형 간염, [키워드] Hepatitis B virus interferon λ progression of disease treatment effect [DOI] 10.13345/j.cjb.210310 [Article Type] Review
Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience42 Published on 2022-02-072022-10-29 Journal: Proceedings of the National Academy of Sciences of [Category] Coronavirus, COVID19(2023년), MERS, SARS, [키워드] collected evaluate lack Reply treatment effect [DOI] 10.1073/pnas.2103168119 PMC 바로가기 [Article Type] 42
Efficacy of the Common Elements Treatment Approach (CETA) for Unhealthy Alcohol Use Among Adults with HIV in Zambia: Results from a Pilot Randomized Controlled TrialRandomized Controlled Trial Published on 2022-02-012022-10-05 Journal: AIDS and Behavior [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI alcohol assigned baseline clinically common Comorbidities Comorbidity Controlled COVID-19 Depression effect size Effectiveness Efficacy element enrolled feasible finding Follow-up greater HIV identification in both groups Intervention Mental mental health outcome participant PLWH Randomized Randomized controlled trial receive reducing reduction reductions in Result Significant significantly substance Substance use Support Symptoms Test tested therapy those with comorbidities trauma treatment effect trial ended unhealthy alcohol use were measured with HIV Zambia [DOI] 10.1007/s10461-021-03408-4 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical TrialCOVID-19가 있는 중환자의 장기 지원이 없는 날에 회복기 혈장의 효과: 무작위 임상 시험Randomized Controlled Trial Published on 2021-11-022022-09-12 Journal: JAMA [Category] MERS, 임상, 진단, [키워드] 48 hour ABO-compatible convalescent plasma adjusted adverse event assigned benefit clinical convalescent plasma convalescent plasma group COVID-19 criterion Critically ill Critically ill patient cumulative Day days alive defined determine died domain Effect end point enrolled event Evidence futility greater hospital Ill Immunoglobulin IMPROVE In-hospital in-hospital mortality rate Inconclusive intensive care Intervention Invasive mechanical ventilation IQR less likelihood Logistic median median age Odds ratio Open-label organ organ support outcome Oxygenation participant Patient posterior probability primary analysis Primary outcome progression randomization Randomized receive REMAP-CAP reported secondary outcome Secondary outcomes Serious Adverse Events survival the median threshold Treatment treatment effect Trial venous thromboembolic Volume with COVID-19 women World Health Organization [DOI] 10.1001/jama.2021.18178 PMC 바로가기 [Article Type] Randomized Controlled Trial
Efficacy of a Single-Session “Empowered Relief” Zoom-Delivered Group Intervention for Chronic Pain: Randomized Controlled Trial Conducted During the COVID-19 PandemicRandomized Controlled Trial Published on 2021-09-102022-10-04 Journal: Journal of Medical Internet Research [Category] SARS, 임상, [키워드] 1:1 age analyzed Care chronic chronic pain Clinical improvement clinically collected Community condition conducted Controlled COVID-19 effect size Efficacy empowered relief female Follow-up greater group Health highest improvement individual intensity intention-to-treat analysis Intervention lack moderate objective outcome Pain pain catastrophizing pain intensity participant Patient performed Pilot test platform Primary outcome Randomized Randomized controlled trial randomized-controlled trial ranged receive reducing reduction Registration reported Result rigorous test Satisfaction secondary outcome Secondary outcomes single-session Sleep disturbance sustained Travel Treatment treatment effect Zoom-delivered [DOI] 10.2196/29672 PMC 바로가기 [Article Type] Randomized Controlled Trial
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialCOVID-19 중환자를 위한 Lopinavir-ritonavir 및 hydroxychloroquine: REMAP-CAP 무작위 대조 시험Randomized Controlled Trial Published on 2021-08-012022-09-11 Journal: Intensive care medicine [Category] Fulltext, SARS, 임상, 치료제, [키워드] Adaptive platform trial adjusted odds ratio antiviral therapy Bayesian combination therapy control group coronavirus disease Coronavirus disease 2019 COVID-19 credible interval Critically ill Critically ill patient critically ill patients cumulative Efficacy expressed group hospital Hydroxychloroquine in-hospital mortality intensive care Intervention Logistic Lopinavir Lopinavir-ritonavir median Ordinal Scale organ organ support outcome pandemic Patient platform Pneumonia posterior probability primary endpoint Probability Randomized Randomized controlled trial reached receive reduced REMAP-CAP Ritonavir survival threshold treatment effect treatment effects with COVID-19 worsened yielding [DOI] 10.1007/s00134-021-06448-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
A novel anti‐inflammatory treatment for bradykinin‐induced sore throat or pharyngitisOriginal Article Published on 2021-06-212022-10-30 Journal: Immunity, Inflammation and Disease [Category] Coronavirus, MERS, SARS, [키워드] A549 cells absence acetyl acetyl salicylic acid alveolar analyzed antibiotic Aspirin bradykinin complex mechanism concentrations COVID‐19 COX described disease Epiairway epithelia epithelial cell exacerbate exacerbated Health IL‐8 immunohistochemistry increase in Inflammation Inflammatory inflammatory condition inflammatory mediator ingredient inhibitor involved lactate dehydrogenase LDH likelihood low dose LTB4 medication mitigate morphology MucilAir nonspecific PGE2 pharyngitis prostaglandin public health Respiratory complications respiratory epithelia respiratory tissue respiratory tissues Result sore throat stimulated Symptom TEER the cell therapeutic window therapy thought tissue transepithelial electrical resistance Treatment treatment effect upper respiratory was measured were used [DOI] 10.1002/iid3.479 PMC 바로가기 [Article Type] Original Article
Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort StudyArticle Published on 2021-05-142022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] average calculated clinical Clinical improvement Clinical outcome confounding factors convalescent plasma coronavirus disease COVID-19 COVID-19 patient COVID-19 patients CP group Critically ill Critically ill patient defined determine discharged disease severity Efficacy group hazard ratio hospital Hospital mortality ICU intensive care intensive care unit IPW laboratory-confirmed SARS-CoV-2 infection life-threatening Life-threatening COVID-19 mechanical ventilation Mortality neutralizing antibody Neutralizing antibody titer not differ occurred Patient patients Primary outcome Probability reduction Respiratory failure SARS-CoV-2 single-center study treatment effect [DOI] 10.3390/jcm10102113 PMC 바로가기 [Article Type] Article
Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) DrugsResearch article Published on 2021-05-012022-10-05 Journal: Value in health : the journal of the International [Category] 임상, [키워드] Assessing average Care clinical decision clinician coronavirus disease COVID-19 criteria criterion decision decision criteria drug estimate evaluate Experimental drugs highest hypothesis test hypothesis tests IMPROVE magnitude near optimality objective outcome Patient Perspective positive Probability property randomized trial randomized trials reported Result sample sizes standard care statistical statistically significant treat Treatment treatment effect Trial trials [DOI] 10.1016/j.jval.2020.11.019 [Article Type] Research article